Dose tailoring of anti-tumour necrosis factor-alpha therapy delivers useful clinical efficacy in Crohn disease patients experiencing loss of response

2015 ◽  
Vol 45 (2) ◽  
pp. 170-177 ◽  
Author(s):  
S. Ghaly ◽  
S. Costello ◽  
L. Beswick ◽  
A. Pudipeddi ◽  
A. Agarwal ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document